MARÍA SONIA
GAZTAMBIDE SÁENZ
Novartis (Sweden)
Täby, SueciaPublikationen in Zusammenarbeit mit Forschern von Novartis (Sweden) (2)
2010
-
Effect of nateglinide on the incidence of diabetes and cardiovascular events
New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476
-
Effect of valsartan on the incidence of diabetes and cardiovascular events
New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490